TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3095150
log Bayes Factor = 65.7208
Chromosome 6   position 30,932,532  (GRCh37) Explore rs3095150 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.002 0.998
E10.3 With ophthalmic complications
0.000 0.003 0.997
E00-E07 Disorders of thyroid gland
0.000 0.003 0.997
L40 Psoriasis
0.997 0.003 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.004 0.996
E05.9 Thyrotoxicosis, unspecified
0.000 0.004 0.996
E11 Non-insulin-dependent diabetes mellitus
0.000 0.006 0.994
E16 Other disorders of pancreatic internal secretion
0.000 0.006 0.994
E14 Unspecified diabetes mellitus
0.000 0.010 0.990
E11.9 Without complications
0.000 0.010 0.990
E16.2 Hypoglycaemia, unspecified
0.000 0.012 0.988
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.013 0.987
M06.9 Rheumatoid arthritis, unspecified
0.000 0.016 0.984
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.017 0.983
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.027 0.973
L40.5 Arthropathic psoriasis
0.971 0.029 0.000
E10.4 With neurological complications
0.000 0.035 0.965
L40.0 Psoriasis vulgaris
0.965 0.035 0.000
E83.1 Disorders of iron metabolism
0.964 0.036 0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.055 0.945
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.064 0.936
E10.1 With ketoacidosis
0.000 0.066 0.934
E11.5 With peripheral circulatory complications
0.000 0.066 0.934
E20-E35 Disorders of other endocrine glands
0.000 0.075 0.925
E10.5 With peripheral circulatory complications
0.000 0.076 0.924
E10.2 With renal complications
0.000 0.091 0.909
E14.9 Without complications
0.000 0.114 0.886
E14.3 With ophthalmic complications
0.000 0.114 0.886
E10.6 With other specified complications
0.000 0.116 0.884
G35 Multiple sclerosis
0.881 0.119 0.000
E14.8 With unspecified complications
0.000 0.125 0.875
E10.0 With coma
0.000 0.130 0.870
E50-E64 Other nutritional deficiencies
0.000 0.142 0.858
E14.6 With other specified complications
0.000 0.144 0.856
E34 Other endocrine disorders
0.000 0.154 0.846
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.158 0.842
E16.1 Other hypoglycaemia
0.000 0.159 0.841
E05.8 Other thyrotoxicosis
0.000 0.163 0.837
L40.8 Other psoriasis
0.831 0.169 0.000
E10.8 With unspecified complications
0.000 0.169 0.831
E22 Hyperfunction of pituitary gland
0.000 0.176 0.824
L40.1 Generalised pustular psoriasis
0.823 0.177 0.000
E23 Hypofunction and other disorders of pituitary gland
0.000 0.181 0.819
E14.2 Withrenal complications
0.000 0.187 0.813
E13 Other specified diabetes mellitus
0.000 0.189 0.811
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.211 0.789
E55 Vitamin D deficiency
0.000 0.213 0.787
E83 Disorders of mineral metabolism
0.778 0.222 0.000
E23.0 Hypopituitarism
0.000 0.226 0.774
E29 Testicular dysfunction
0.000 0.233 0.767
E83.5 Disorders of calcium metabolism
0.766 0.234 0.000
L40.3 Pustulosis palmaris et plantaris
0.752 0.248 0.000
E14.1 With ketoacidosis
0.000 0.251 0.749
E34.9 Endocrine disorder, unspecified
0.000 0.255 0.745
E55.9 Vitamin D deficiency, unspecified
0.000 0.264 0.736
E11.0 With coma
0.000 0.274 0.726
E22.1 Hyperprolactinaemia
0.000 0.276 0.724
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.277 0.723
E10.7 With multiple complications
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E07 Other disorders of thyroid
0.000 0.284 0.716
E05.5 Thyroid crisis or storm
0.000 0.285 0.715
E05.4 Thyrotoxicosis factitia
0.000 0.285 0.715
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.285 0.715
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.285 0.715
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.285 0.715
E00 Congenital iodine-deficiency syndrome
0.000 0.285 0.715
L40.4 Guttate psoriasis
0.715 0.285 0.000
L40.2 Acrodermatitis continua
0.715 0.285 0.000
E15 Nondiabetic hypoglycaemic coma
0.000 0.286 0.714
E11.7 With multiple complications
0.000 0.287 0.712
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.288 0.712
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.288 0.712
E16.4 Abnormal secretion of gastrin
0.000 0.288 0.712
E16.3 Increased secretion of glucagon
0.000 0.288 0.712
E58 Dietary calcium deficiency
0.000 0.290 0.710
E14.7 With multiple complications
0.000 0.290 0.710
E14.0 With coma
0.000 0.290 0.710
E34.0 Carcinoid syndrome
0.000 0.292 0.708
E27 Other disorders of adrenal gland
0.000 0.296 0.704
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.296 0.704
E11.2 With renal complications
0.000 0.301 0.699
E11.8 With unspecified complications
0.000 0.305 0.695
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.308 0.692
E27.1 Primary adrenocortical insufficiency
0.000 0.321 0.679
E11.6 With other specified complications
0.000 0.322 0.678
E14.4 With neurological complications
0.000 0.324 0.676
E13.9 Without complications
0.000 0.327 0.673
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.337 0.663
E32 Diseases of thymus
0.000 0.337 0.663
E31 Polyglandular dysfunction
0.000 0.337 0.663
E30 Disorders of puberty, not elsewhere classified
0.000 0.337 0.663
E29.1 Testicular hypofunction
0.000 0.345 0.655
E25 Adrenogenital disorders
0.000 0.352 0.648
E20 Hypoparathyroidism
0.000 0.354 0.646
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.357 0.643
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.364 0.636
E61 Deficiency of other nutrient elements
0.000 0.365 0.635
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.385 0.615
E63 Other nutritional deficiencies
0.000 0.385 0.615
E50 Vitamin A deficiency
0.000 0.385 0.615
E60 Dietary zinc deficiency
0.000 0.385 0.615
E59 Dietary selenium deficiency
0.000 0.385 0.615
E54 Ascorbic acid deficiency
0.000 0.385 0.615
E52 Niacin deficiency [pellagra]
0.000 0.385 0.615
E34.8 Other specified endocrine disorders
0.000 0.386 0.614
E34.5 Androgen resistance syndrome
0.000 0.393 0.607
E34.4 Constitutional tall stature
0.000 0.393 0.607
E34.3 Short stature, not elsewhere classified
0.000 0.393 0.607
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.393 0.607
E34.1 Other hypersecretion of intestinal hormones
0.000 0.393 0.607
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.403 0.597
E24 Cushing's syndrome
0.000 0.403 0.597
E51 Thiamine deficiency
0.000 0.403 0.597
E56 Other vitamin deficiencies
0.000 0.404 0.596
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.409 0.591
E22.8 Other hyperfunction of pituitary gland
0.000 0.409 0.591
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.413 0.587
E23.1 Drug-induced hypopituitarism
0.000 0.413 0.587
E23.2 Diabetes insipidus
0.000 0.414 0.586
E13.3 With ophthalmic complications
0.000 0.414 0.586
E11.1 With ketoacidosis
0.000 0.415 0.585
G35-G37 Demyelinating diseases of the central nervous system
0.582 0.418 0.000
E13.8 With unspecified complications
0.000 0.419 0.581
E13.7 With multiple complications
0.000 0.419 0.581
E13.6 With other specified complications
0.000 0.419 0.581
E13.5 With peripheral circulatory complications
0.000 0.419 0.581
E13.4 With neurological complications
0.000 0.419 0.581
E13.2 With renal complications
0.000 0.419 0.581
E13.1 With ketoacidosis
0.000 0.419 0.581
E13.0 With coma
0.000 0.419 0.581
E11.3 With ophthalmic complications
0.000 0.421 0.579
E03 Other hypothyroidism
0.000 0.426 0.574
E14.5 With peripheral circulatory complications
0.000 0.432 0.568
E55.0 Rickets, active
0.000 0.436 0.564
E07.9 Disorder of thyroid, unspecified
0.000 0.438 0.562
E83.8 Other disorders of mineral metabolism
0.558 0.442 0.000
E83.2 Disorders of zinc metabolism
0.558 0.442 0.000
E83.0 Disorders of copper metabolism
0.558 0.442 0.000
E23.7 Disorder of pituitary gland, unspecified
0.000 0.442 0.558
E29.9 Testicular dysfunction, unspecified
0.000 0.450 0.550
E29.8 Other testicular dysfunction
0.000 0.450 0.550
E29.0 Testicular hyperfunction
0.000 0.450 0.550
E83.9 Disorder of mineral metabolism, unspecified
0.538 0.462 0.000
E28 Ovarian dysfunction
0.000 0.470 0.530
E22.0 Acromegaly and pituitary gigantism
0.000 0.475 0.525
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.475 0.525
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.477 0.523
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E07.1 Dyshormogenetic goitre
0.000 0.486 0.513
E07.0 Hypersecretion of calcitonin
0.000 0.486 0.513
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.487 0.512
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.487 0.512
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.487 0.512
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.487 0.512
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.487 0.512
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.487 0.512
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.487 0.512
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.487 0.512
E27.5 Adrenomedullary hyperfunction
0.000 0.495 0.505
E27.0 Other adrenocortical overactivity
0.000 0.495 0.505
E40-E46 Malnutrition
0.000 0.497 0.503
E61.1 Iron deficiency
0.000 0.502 0.498
G37 Other demyelinating diseases of central nervous system
0.491 0.509 0.000
E27.2 Addisonian crisis
0.000 0.517 0.482
E11.4 With neurological complications
0.000 0.517 0.482
E26 Hyperaldosteronism
0.000 0.523 0.476
E83.4 Disorders of magnesium metabolism
0.476 0.524 0.000
E30.9 Disorder of puberty, unspecified
0.000 0.524 0.475
E30.8 Other disorders of puberty
0.000 0.524 0.475
E30.1 Precocious puberty
0.000 0.524 0.475
E30.0 Delayed puberty
0.000 0.524 0.475
E31.9 Polyglandular dysfunction, unspecified
0.000 0.524 0.475
E31.8 Other polyglandular dysfunction
0.000 0.524 0.475
E31.1 Polyglandular hyperfunction
0.000 0.524 0.475
E31.0 Autoimmune polyglandular failure
0.000 0.524 0.475
E32.9 Disease of thymus, unspecified
0.000 0.524 0.475
E32.8 Other diseases of thymus
0.000 0.524 0.475
E32.1 Abscess of thymus
0.000 0.524 0.475
E32.0 Persistent hyperplasia of thymus
0.000 0.524 0.475
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.524 0.475
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.524 0.475
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.524 0.475
E23.6 Other disorders of pituitary gland
0.000 0.526 0.473
E25.9 Adrenogenital disorder, unspecified
0.000 0.535 0.465
E25.8 Other adrenogenital disorders
0.000 0.535 0.465
E20.8 Other hypoparathyroidism
0.000 0.536 0.463
E20.1 Pseudohypoparathyroidism
0.000 0.536 0.463
E20.0 Idiopathic hypoparathyroidism
0.000 0.536 0.463
G36 Other acute disseminated demyelination
0.458 0.541 0.000
E24.2 Drug-induced Cushing's syndrome
0.000 0.542 0.458
E61.9 Deficiency of nutrient element, unspecified
0.000 0.544 0.455
E61.8 Deficiency of other specified nutrient elements
0.000 0.544 0.455
E61.7 Deficiency of multiple nutrient elements
0.000 0.544 0.455
E61.6 Vanadium deficiency
0.000 0.544 0.455
E61.5 Molybdenum deficiency
0.000 0.544 0.455
E61.4 Chromium deficiency
0.000 0.544 0.455
E61.3 Manganese deficiency
0.000 0.544 0.455
E61.0 Copper deficiency
0.000 0.544 0.455
E07.8 Other specified disorders of thyroid
0.000 0.549 0.451
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.550 0.450
E20.9 Hypoparathyroidism, unspecified
0.000 0.553 0.447
E50.9 Vitamin A deficiency, unspecified
0.000 0.559 0.441
E50.8 Other manifestations of vitamin A deficiency
0.000 0.559 0.441
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.559 0.441
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.559 0.441
E50.5 Vitamin A deficiency with night blindness
0.000 0.559 0.441
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.559 0.441
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.559 0.441
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.559 0.441
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.559 0.441
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.559 0.441
E63.9 Nutritional deficiency, unspecified
0.000 0.559 0.441
E63.8 Other specified nutritional deficiencies
0.000 0.559 0.441
E63.1 Imbalance of constituents of food intake
0.000 0.559 0.441
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.559 0.441
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.559 0.441
E64.8 Sequelae of other nutritional deficiencies
0.000 0.559 0.441
E64.3 Sequelae of rickets
0.000 0.559 0.441
E64.2 Sequelae of vitamin C deficiency
0.000 0.559 0.441
E64.1 Sequelae of vitamin A deficiency
0.000 0.559 0.441
E64.0 Sequelae of protein-energy malnutrition
0.000 0.559 0.441
G37.9 Demyelinating disease of central nervous system, unspecified
0.438 0.562 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.572 0.428
E24.3 Ectopic ACTH syndrome
0.000 0.572 0.428
E24.1 Nelson's syndrome
0.000 0.572 0.428
E51.9 Thiamine deficiency, unspecified
0.000 0.572 0.428
E51.8 Other manifestations of thiamine deficiency
0.000 0.572 0.428
E51.1 Beriberi
0.000 0.572 0.428
E56.9 Vitamin deficiency, unspecified
0.000 0.573 0.427
E56.8 Deficiency of other vitamins
0.000 0.573 0.427
E56.0 Deficiency of vitamin E
0.000 0.573 0.427
E61.2 Magnesium deficiency
0.000 0.574 0.426
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.577 0.423
E27.8 Other specified disorders of adrenal gland
0.000 0.583 0.417
E24.8 Other Cushing's syndrome
0.000 0.587 0.413
E03.5 Myxoedema coma
0.000 0.588 0.412
E03.4 Atrophy of thyroid (acquired)
0.000 0.588 0.412
E03.3 Postinfectious hypothyroidism
0.000 0.588 0.412
E03.1 Congenital hypothyroidism without goitre
0.000 0.588 0.412
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.588 0.412
E51.2 Wernicke's encephalopathy
0.000 0.590 0.410
E56.1 Deficiency of vitamin K
0.000 0.592 0.408
E06 Thyroiditis
0.000 0.600 0.400
E24.0 Pituitary-dependent Cushing's disease
0.000 0.600 0.400
E28.9 Ovarian dysfunction, unspecified
0.000 0.620 0.380
E28.8 Other ovarian dysfunction
0.000 0.620 0.380
E28.1 Androgen excess
0.000 0.620 0.380
E28.0 Oestrogen excess
0.000 0.620 0.380
M06 Other rheumatoid arthritis
0.000 0.623 0.377
E24.9 Cushing's syndrome, unspecified
0.000 0.626 0.374
G37.8 Other specified demyelinating diseases of central nervous system
0.373 0.627 0.000
G36.0 Neuromyelitis optica [Devic]
0.370 0.630 0.000
K90 Intestinal malabsorption
0.000 0.634 0.366
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.639 0.361
E45 Retarded development following protein-energy malnutrition
0.000 0.639 0.361
E43 Unspecified severe protein-energy malnutrition
0.000 0.639 0.361
E42 Marasmic kwashiorkor
0.000 0.639 0.361
E41 Nutritional marasmus
0.000 0.639 0.361
E40 Kwashiorkor
0.000 0.639 0.361
E83.3 Disorders of phosphorus metabolism
0.352 0.648 0.000
G37.5 Concentric sclerosis [Balo]
0.352 0.648 0.000
G37.4 Subacute necrotising myelitis
0.352 0.648 0.000
G37.2 Central pontine myelinolysis
0.352 0.648 0.000
G37.1 Central demyelination of corpus callosum
0.352 0.648 0.000
G37.0 Diffuse sclerosis
0.352 0.648 0.000
E03.9 Hypothyroidism, unspecified
0.000 0.649 0.351
E27.9 Disorder of adrenal gland, unspecified
0.000 0.652 0.348
E26.8 Other hyperaldosteronism
0.000 0.658 0.342
E26.1 Secondary hyperaldosteronism
0.000 0.658 0.342
M06.4 Inflammatory polyarthropathy
0.000 0.658 0.342
E03.8 Other specified hypothyroidism
0.000 0.662 0.338
E28.3 Primary ovarian failure
0.000 0.667 0.333
G36.9 Acute disseminated demyelination, unspecified
0.329 0.671 0.000
G36.8 Other specified acute disseminated demyelination
0.329 0.671 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.329 0.671 0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.000 0.678 0.322
E53 Deficiency of other B group vitamins
0.000 0.680 0.320
E26.9 Hyperaldosteronism, unspecified
0.001 0.683 0.316
E28.2 Polycystic ovarian syndrome
0.000 0.685 0.314
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.696 0.304
E06.5 Other chronic thyroiditis
0.000 0.711 0.289
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.289 0.711 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.001 0.711 0.288
E06.4 Drug-induced thyroiditis
0.000 0.713 0.287
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.713 0.287
E06.1 Subacute thyroiditis
0.000 0.713 0.287
E06.0 Acute thyroiditis
0.000 0.713 0.287
E65-E68 Obesity and other hyperalimentation
0.000 0.715 0.285
L40-L45 Papulosquamous disorders
0.276 0.724 0.000
M06.2 Rheumatoid bursitis
0.000 0.729 0.271
M06.1 Adult-onset Still's disease
0.000 0.729 0.271
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.730 0.270
K90.3 Pancreatic steatorrhoea
0.000 0.737 0.263
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.737 0.263
K90.1 Tropical sprue
0.000 0.737 0.263
E44.1 Mild protein-energy malnutrition
0.000 0.741 0.259
E44.0 Moderate protein-energy malnutrition
0.000 0.741 0.259
E04 Other non-toxic goitre
0.000 0.744 0.256
M06.8 Other specified rheumatoid arthritis
0.000 0.748 0.252
K90.9 Intestinal malabsorption, unspecified
0.000 0.750 0.250
M06.48 Inflammatory polyarthropathy (Other)
0.000 0.755 0.245
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.000 0.755 0.245
M06.46 Inflammatory polyarthropathy (Lower leg)
0.000 0.755 0.245
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.000 0.755 0.245
M06.44 Inflammatory polyarthropathy (Hand)
0.000 0.755 0.245
M06.43 Inflammatory polyarthropathy (Forearm)
0.000 0.755 0.245
M06.42 Inflammatory polyarthropathy (Upper arm)
0.000 0.755 0.245
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.000 0.755 0.245
K90.8 Other intestinal malabsorption
0.000 0.765 0.235
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.770 0.230
M06.3 Rheumatoid nodule
0.000 0.770 0.230
E53.1 Pyridoxine deficiency
0.000 0.770 0.230
E53.0 Riboflavin deficiency
0.000 0.770 0.230
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.779 0.221
E21.4 Other specified disorders of parathyroid gland
0.000 0.782 0.218
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.000 0.783 0.217
E21.2 Other hyperparathyroidism
0.000 0.788 0.211
E04.9 Non-toxic goitre, unspecified
0.000 0.791 0.209
E26.0 Primary hyperaldosteronism
0.001 0.793 0.206
E67 Other hyperalimentation
0.000 0.795 0.204
E68 Sequelae of hyperalimentation
0.000 0.795 0.204
L42 Pityriasis rosea
0.204 0.796 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.797 0.202
L44 Other papulosquamous disorders
0.198 0.802 0.000
L41 Parapsoriasis
0.198 0.802 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.198 0.802 0.000
M06.19 Adult-onset Still's disease (Site unspecified)
0.000 0.806 0.194
M06.18 Adult-onset Still's disease (Other)
0.000 0.806 0.194
M06.17 Adult-onset Still's disease (Ankle and foot)
0.000 0.806 0.194
M06.16 Adult-onset Still's disease (Lower leg)
0.000 0.806 0.194
M06.15 Adult-onset Still's disease (Pelvic region and thigh)
0.000 0.806 0.194
M06.14 Adult-onset Still's disease (Hand)
0.000 0.806 0.194
M06.13 Adult-onset Still's disease (Forearm)
0.000 0.806 0.194
M06.12 Adult-onset Still's disease (Upper arm)
0.000 0.806 0.194
M06.11 Adult-onset Still's disease (Shoulder region)
0.000 0.806 0.194
M06.10 Adult-onset Still's disease (Multiple sites)
0.000 0.806 0.194
M06.29 Rheumatoid bursitis (Site unspecified)
0.000 0.806 0.194
M06.28 Rheumatoid bursitis (Other)
0.000 0.806 0.194
M06.27 Rheumatoid bursitis (Ankle and foot)
0.000 0.806 0.194
M06.26 Rheumatoid bursitis (Lower leg)
0.000 0.806 0.194
M06.25 Rheumatoid bursitis (Pelvic region and thigh)
0.000 0.806 0.194
M06.24 Rheumatoid bursitis (Hand)
0.000 0.806 0.194
M06.23 Rheumatoid bursitis (Forearm)
0.000 0.806 0.194
M06.22 Rheumatoid bursitis (Upper arm)
0.000 0.806 0.194
M06.21 Rheumatoid bursitis (Shoulder region)
0.000 0.806 0.194
M06.20 Rheumatoid bursitis (Multiple sites)
0.000 0.806 0.194
E06.9 Thyroiditis, unspecified
0.001 0.808 0.192
E04.8 Other specified non-toxic goitre
0.000 0.816 0.184
M06.88 Other specified rheumatoid arthritis (Other)
0.000 0.819 0.181
M06.87 Other specified rheumatoid arthritis (Ankle and foot)
0.000 0.819 0.181
M06.86 Other specified rheumatoid arthritis (Lower leg)
0.000 0.819 0.181
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)
0.000 0.819 0.181
M06.84 Other specified rheumatoid arthritis (Hand)
0.000 0.819 0.181
M06.83 Other specified rheumatoid arthritis (Forearm)
0.000 0.819 0.181
M06.82 Other specified rheumatoid arthritis (Upper arm)
0.000 0.819 0.181
M06.81 Other specified rheumatoid arthritis (Shoulder region)
0.000 0.819 0.181
M06.80 Other specified rheumatoid arthritis (Multiple sites)
0.000 0.819 0.181
M06.32 Rheumatoid nodule (Upper arm)
0.000 0.826 0.174
E53.9 Vitamin B deficiency, unspecified
0.000 0.827 0.173
M06.39 Rheumatoid nodule (Site unspecified)
0.000 0.835 0.165
M06.38 Rheumatoid nodule (Other)
0.000 0.835 0.165
M06.36 Rheumatoid nodule (Lower leg)
0.000 0.835 0.165
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.000 0.835 0.165
M06.33 Rheumatoid nodule (Forearm)
0.000 0.835 0.165
M06.31 Rheumatoid nodule (Shoulder region)
0.000 0.835 0.165
J45.9 Asthma, unspecified
0.000 0.837 0.163
M06.89 Other specified rheumatoid arthritis (Site unspecified)
0.000 0.838 0.162
E06.3 Autoimmune thyroiditis
0.000 0.838 0.162
M06.37 Rheumatoid nodule (Ankle and foot)
0.000 0.844 0.156
M45.X9 Ankylosing spondylitis (Site unspecified)
0.000 0.847 0.153
M06.30 Rheumatoid nodule (Multiple sites)
0.000 0.852 0.148
E46 Unspecified protein-energy malnutrition
0.001 0.852 0.147
E67.8 Other specified hyperalimentation
0.000 0.853 0.147
E67.3 Hypervitaminosis D
0.000 0.853 0.147
E67.2 Megavitamin-B6 syndrome
0.000 0.853 0.147
E67.1 Hypercarotenaemia
0.000 0.853 0.147
E67.0 Hypervitaminosis A
0.000 0.853 0.147
M06.34 Rheumatoid nodule (Hand)
0.000 0.856 0.144
L41.9 Parapsoriasis, unspecified
0.142 0.858 0.000
L41.8 Other parapsoriasis
0.142 0.858 0.000
L41.5 Retiform parapsoriasis
0.142 0.858 0.000
L41.4 Large plaque parapsoriasis
0.142 0.858 0.000
L41.3 Small plaque parapsoriasis
0.142 0.858 0.000
L41.2 Lymphomatoid papulosis
0.142 0.858 0.000
L41.1 Pityriasis lichenoides chronica
0.142 0.858 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.142 0.858 0.000
L44.9 Papulosquamous disorder, unspecified
0.142 0.858 0.000
L44.8 Other specified papulosquamous disorders
0.142 0.858 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.142 0.858 0.000
L44.3 Lichen ruber moniliformis
0.142 0.858 0.000
L44.2 Lichen striatus
0.142 0.858 0.000
L44.1 Lichen nitidus
0.142 0.858 0.000
L44.0 Pityriasis rubra pilaris
0.142 0.858 0.000
M06.0 Seronegative rheumatoid arthritis
0.000 0.860 0.140
E04.0 Non-toxic diffuse goitre
0.000 0.867 0.133
M45 Ankylosing spondylitis
0.000 0.869 0.131
E21.3 Hyperparathyroidism, unspecified
0.000 0.869 0.131
E21.0 Primary hyperparathyroidism
0.000 0.874 0.126
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.126 0.874 0.000
T43.2 Other and unspecified antidepressants
0.122 0.878 0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.000 0.879 0.121
T36-T50 Poisoning by drugs, medicaments and biological substances
0.118 0.882 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.116 0.884 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.114 0.886 0.000
L43 Lichen planus
0.113 0.887 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.111 0.889 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.111 0.889 0.000
M45.X2 Ankylosing spondylitis (Cervical region)
0.000 0.894 0.106
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.105 0.895 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.104 0.896 0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.000 0.896 0.104
M45.X6 Ankylosing spondylitis (Lumbar region)
0.000 0.897 0.103
T43.6 Psychostimulants with abuse potential
0.103 0.897 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.103 0.897 0.000
M06.08 Seronegative rheumatoid arthritis (Other)
0.000 0.899 0.100
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.000 0.899 0.100
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.000 0.899 0.100
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.000 0.899 0.100
T43.9 Psychotropic drug, unspecified
0.097 0.903 0.000
M06.04 Seronegative rheumatoid arthritis (Hand)
0.000 0.903 0.097
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.097 0.903 0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.000 0.904 0.095
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.095 0.905 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.094 0.906 0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)
0.000 0.906 0.094
M45.X7 Ankylosing spondylitis (Lumbosacral region)
0.000 0.906 0.094
M45.X5 Ankylosing spondylitis (Thoracolumbar region)
0.000 0.906 0.094
M45.X4 Ankylosing spondylitis (Thoracic region)
0.000 0.906 0.094
M45.X3 Ankylosing spondylitis (Cervicothoracic region)
0.000 0.906 0.094
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)
0.000 0.906 0.094
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.093 0.907 0.000
T47.2 Stimulant laxatives
0.092 0.908 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.092 0.908 0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)
0.000 0.908 0.091
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.090 0.909 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.090 0.909 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.090 0.910 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.090 0.910 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.089 0.911 0.000
T47.0 Histamine H(2)-receptor antagonists
0.088 0.912 0.000
T47.4 Other laxatives
0.087 0.913 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.086 0.914 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.086 0.914 0.000
T47.6 Antidiarrhoeal drugs
0.086 0.914 0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)
0.000 0.915 0.085
T36 Poisoning by systemic antibiotics
0.085 0.915 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.085 0.915 0.000
E66 Obesity
0.000 0.916 0.084
E53.8 Deficiency of other specified B group vitamins
0.000 0.917 0.083
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.083 0.917 0.000
T45.0 Antiallergic and antiemetic drugs
0.082 0.918 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.082 0.918 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.082 0.918 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.082 0.918 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.082 0.918 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.082 0.918 0.000
T44.0 Anticholinesterase agents
0.082 0.918 0.000
L43.3 Subacute (active) lichen planus
0.081 0.919 0.000
L43.2 Lichenoid drug reaction
0.081 0.919 0.000
L43.1 Bullous lichen planus
0.081 0.919 0.000
L43.0 Hypertrophic lichen planus
0.081 0.919 0.000
E65 Localised adiposity
0.001 0.920 0.079
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.080 0.920 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.080 0.920 0.000
T47.7 Emetics
0.080 0.920 0.000
T47.5 Digestants
0.080 0.920 0.000
T47.3 Saline and osmotic laxatives
0.080 0.920 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.079 0.921 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.077 0.923 0.000
L43.8 Other lichen planus
0.076 0.923 0.000
T48.5 Anti-common-cold drugs
0.076 0.924 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.075 0.925 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.075 0.925 0.000
T50.8 Diagnostic agents
0.075 0.925 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.074 0.926 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.074 0.926 0.000
T42.3 Barbiturates
0.074 0.926 0.000
T42.2 Succinimides and oxazolidinediones
0.074 0.926 0.000
J33.0 Polyp of nasal cavity
0.000 0.926 0.074
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.073 0.927 0.000
E04.2 Non-toxic multinodular goitre
0.000 0.928 0.072
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.072 0.928 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.071 0.929 0.000
T42.1 Iminostilbenes
0.070 0.930 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.